{"data":{"id":"us-il/410-ilcs-416-30","jurisdiction":"us-il","citation":"410 ILCS 416/30","heading":"","body":"Reimbursement status as undue inducement. Reimbursement of ancillary costs incurred by a subject under the program:\n(1) does not constitute an undue inducement to participate in a clinical trial;\n(2) is not considered coercion or the exertion of undue influence to participate in a clinical trial; and\n(3) shall be deemed to accomplish parity in access to clinical trials and remove barriers to participation in clinical trials for financially burdened subjects.","path":["CHAPTER 410 PUBLIC HEALTH","Clinical Trial Participation Program Act."],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=4047\u0026ChapterID=35\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:35Z","sha256":"caf89e90fc5809e377d5fcfcd9f415fa2ebba873bb466a7447a7497ab8826a45","source_id":"us-il","stale":false,"prev":"us-il/410-ilcs-416-25","next":"us-il/410-ilcs-416-35"},"notice":"GroundRules: Original legal text. Not legal advice."}